Elite Pharmaceuticals Inc (ELTP)

[carbonfiltered]

"We launched Phendimetrazine, Isradipine and Hydroxyzine and strengthened our current generic profile. We created infrastructure for the [Indiscernible] and built a new facility."

We haven't given any weight to the fact that they built a new facility. That's a big deal, no weak company is going to go through the effort of building a new facility, hiring more people, signing more partnership contracts, submitting 4 new ANDAs (one per quarter), and have a potential Blockbuster drug in development (sequestox first of its kind) using patented technology that can be used in other opioids. AND have an income from current generics that contributes to R&D. Just saying, I think there is a ton of upside here.